Therefore, our goal is to determine through MR analysis whether PC16 has a causal relationship with GBM and to clarify whether FGF21 as an intermediary participates in mediating this causal relationship and to quantify its mediation proportion. The gene discussed is FGF21; the disease is glioblastoma.